In an article titled “Why so many pertussis outbreaks despite acellular pertussis vaccine? A call to action” (published February 16, 2016), Dr. Christoper J. Harrison’s disclosure information was imprecisely stated. His institution received grant support for a study on hexavalent infant vaccine containing pertussis from GlaxoSmithKline, and he was the local primary investigator.
